BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 16501564)

  • 1. Immunohistochemical investigation of tumorigenic pathways in small intestinal adenocarcinoma: a comparison with colorectal adenocarcinoma.
    Zhang MQ; Chen ZM; Wang HL
    Mod Pathol; 2006 Apr; 19(4):573-80. PubMed ID: 16501564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical analysis of adenocarcinoma of the small intestine: a tissue microarray study.
    Svrcek M; Jourdan F; Sebbagh N; Couvelard A; Chatelain D; Mourra N; Olschwang S; Wendum D; Fléjou JF
    J Clin Pathol; 2003 Dec; 56(12):898-903. PubMed ID: 14645346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical investigation of tumorigenic pathways in sinonasal intestinal-type adenocarcinoma. A tissue microarray analysis of 62 cases.
    Franchi A; Palomba A; Fondi C; Miligi L; Paglierani M; Pepi M; Santucci M
    Histopathology; 2011 Jul; 59(1):98-105. PubMed ID: 21668475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of hMLH1, hMSH2 and hMSH6 in small intestinal carcinomas.
    Gu MJ; Bae YK; Kim A; Hong SM; Yu E; Kim J; Jang KT; Chang HK; Jung ES; Bae HI; Yoon GS; Kim JM; Kim JY; Kim GI; Oh YH; Jang KY; Jun SY; Eom DW; Kwon KW; Kang GH; Park JB; Hong SW; Jung SJ; Lee JS;
    Hepatogastroenterology; 2012 Oct; 59(119):2228-32. PubMed ID: 22456432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An insight into the genetic pathway of adenocarcinoma of the small intestine.
    Wheeler JM; Warren BF; Mortensen NJ; Kim HC; Biddolph SC; Elia G; Beck NE; Williams GT; Shepherd NA; Bateman AC; Bodmer WF
    Gut; 2002 Feb; 50(2):218-23. PubMed ID: 11788563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between hMLH1/hMSH2 and p53 protein expression in sporadic colorectal cancer.
    Park IJ; Kim HC; Kim JS; Yu ES; Yu CS; Kim JC
    Hepatogastroenterology; 2005; 52(62):450-4. PubMed ID: 15816455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumors.
    Marcus VA; Madlensky L; Gryfe R; Kim H; So K; Millar A; Temple LK; Hsieh E; Hiruki T; Narod S; Bapat BV; Gallinger S; Redston M
    Am J Surg Pathol; 1999 Oct; 23(10):1248-55. PubMed ID: 10524526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sporadic microsatellite instability-high colon cancers rarely display immunohistochemical evidence of Wnt signaling activation.
    Panarelli NC; Vaughn CP; Samowitz WS; Yantiss RK
    Am J Surg Pathol; 2015 Mar; 39(3):313-7. PubMed ID: 25602793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microsatellite instability in colorectal carcinoma. The comparison of immunohistochemistry and molecular biology suggests a role for hMSH6 [correction of hMLH6] immunostaining.
    Rigau V; Sebbagh N; Olschwang S; Paraf F; Mourra N; Parc Y; Flejou JF
    Arch Pathol Lab Med; 2003 Jun; 127(6):694-700. PubMed ID: 12741892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical pattern of hMSH2/hMLH1 in familial and sporadic colorectal, gastric, endometrial and ovarian carcinomas with instability in microsatellite sequences.
    Chiaravalli AM; Furlan D; Facco C; Tibiletti MG; Dionigi A; Casati B; Albarello L; Riva C; Capella C
    Virchows Arch; 2001 Jan; 438(1):39-48. PubMed ID: 11213834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of mismatch repair proteins, beta catenin, and E cadherin in intestinal-type sinonasal adenocarcinoma.
    Perez-Ordonez B; Huynh NN; Berean KW; Jordan RC
    J Clin Pathol; 2004 Oct; 57(10):1080-3. PubMed ID: 15452164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical pattern of MLH1/MSH2 expression is related to clinical and pathological features in colorectal adenocarcinomas with microsatellite instability.
    Lanza G; Gafà R; Maestri I; Santini A; Matteuzzi M; Cavazzini L
    Mod Pathol; 2002 Jul; 15(7):741-9. PubMed ID: 12118112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis.
    Young J; Simms LA; Biden KG; Wynter C; Whitehall V; Karamatic R; George J; Goldblatt J; Walpole I; Robin SA; Borten MM; Stitz R; Searle J; McKeone D; Fraser L; Purdie DR; Podger K; Price R; Buttenshaw R; Walsh MD; Barker M; Leggett BA; Jass JR
    Am J Pathol; 2001 Dec; 159(6):2107-16. PubMed ID: 11733361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA mismatch repair deficiency but not ARID1A loss is associated with prognosis in small intestinal adenocarcinoma.
    González I; Goyal B; Xia MD; Pai RK; Ma C
    Hum Pathol; 2019 Mar; 85():18-26. PubMed ID: 30381262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct secreted Frizzled receptor protein 1 staining pattern in patients with hyperplastic polyposis coli syndrome.
    Oberschmid BI; Dietmaier W; Hartmann A; Dahl E; Klopocki E; Beatty BG; Hyman NH; Blaszyk H
    Arch Pathol Lab Med; 2004 Sep; 128(9):967-73. PubMed ID: 15335268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue microarray technology: validation in colorectal carcinoma and analysis of p53, hMLH1, and hMSH2 immunohistochemical expression.
    Jourdan F; Sebbagh N; Comperat E; Mourra N; Flahault A; Olschwang S; Duval A; Hamelin R; Flejou JF
    Virchows Arch; 2003 Aug; 443(2):115-21. PubMed ID: 12802583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sporadic colorectal cancers with defective mismatch repair display a number of specific morphological characteristics: relationship between the expression of hMLH1 and hMSH2 proteins and clinicopathological features of 273 adenocarcinomas.
    Chapusot C; Martin L; Mungra N; Rageot D; Bouvier AM; Bonithon Kopp C; Ponnelle T; Faivre J; Piard F
    Histopathology; 2003 Jul; 43(1):40-7. PubMed ID: 12823711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic and immunohistochemistry characterization of synchronous multiple primary gastric adenocarcinoma.
    Ribeiro U; Jorge UM; Safatle-Ribeiro AV; Yagi OK; Scapulatempo C; Perez RO; Corbett CE; Alves VA; Zilberstein B; Gama-Rodrigues J
    J Gastrointest Surg; 2007 Mar; 11(3):233-9. PubMed ID: 17458592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Large-scale N-terminal deletions but not point mutations stabilize beta-catenin in small bowel carcinomas, suggesting divergent molecular pathways of small and large intestinal carcinogenesis.
    Breuhahn K; Singh S; Schirmacher P; Bläker H
    J Pathol; 2008 Jul; 215(3):300-7. PubMed ID: 18491352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sporadic childhood hepatoblastomas show activation of beta-catenin, mismatch repair defects and p53 mutations.
    Curia MC; Zuckermann M; De Lellis L; Catalano T; Lattanzio R; Aceto G; Veschi S; Cama A; Otte JB; Piantelli M; Mariani-Costantini R; Cetta F; Battista P
    Mod Pathol; 2008 Jan; 21(1):7-14. PubMed ID: 17962810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.